On December 22nd, the Food and Drug Administration (FDA) approved Novo Nordisks oral semaglutide tablet, a 25 mg dose of the same active ingredient found in injectable Wegovy and Ozempic
However, this study was done 15 years ago, with only 60 participants
It requires prompt medical attention and can range from mild, self-limiting episodes to severe, life-threatening complications
Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Age-Related Macular Degeneration Among Adults Without Diabetes
Dozens of new protein- and fiber-rich items are rolling out, such as Krogers Simple Truth Protein product line
The tolerability profile is dominated by GI adverse events at higher rates than earlier-generation GLP-1s, with higher dropout at 12 mg than at 9 mg